CNN legal analysts on Thursday pressed Lanny Davis, Michael Cohen’s former attorney, on the lies his previous client pled guilty to telling. Cohen is a key witness against former President Donald Trump…
By Swati Bhat MUMBAI (Reuters) – India’s monetary policy committee is likely to deliver the expected 25-basis point (bps) rate hike in April, even as global markets lowered rate hike bets from…
By Sameer Manekar and Mehr Bedi (Reuters) – Australia’s economic health will be its central bank’s compass for plotting the course of rate hikes, as stringent regulation insulates its banking sector from…
(Reuters) – Goldman Sachs’ analysts on Sunday said they no longer expect the U.S. Federal Reserve to deliver a rate hike at its March 22 meeting with considerable uncertainty about the path…
By Rodrigo Campos NEW YORK (Reuters) – Emerging markets are facing their demons as traders mull whether U.S. Federal Reserve interest rates will rise as high as 6%, a level that could…
By Fergal Smith TORONTO (Reuters) – Analysts are sticking to their forecasts for a stronger Canadian dollar over the coming year, expecting an improved global economy and less central bank uncertainty that…
(Reuters) – The U.S. Food and Drug Administration neurosciences head Billy Dunn will retire from his role effective immediately, the health regulator told Reuters on Tuesday. Wall Street analysts said Dunn’s departure…
By Steve Scherer OTTAWA (Reuters) – Canada has the firepower to invest billions of dollars in the green transition over the coming years to make it more competitive with the United States,…
BUENOS AIRES (Reuters) – Analysts consulted by Argentina’s central bank expect surging consumer prices to rise slightly this year, the bank said on Friday, which would mark a second straight year of…
By Mathieu Rosemain and Dominique Vidalon PARIS (Reuters) – Casino’s preliminary talks with Teract to combine their French retail activities perplexes some analysts, who say a deal wouldn’t address the supermarket group’s…
By Michael S. Derby NEW YORK (Reuters) – The standoff over the U.S. government’s borrowing limit is unlikely for now to crimp the Federal Reserve’s plans for higher interest rates and to…
(Reuters) – Analysts raised 2023 earnings estimates for Asian companies over the past month, contrasting with the raft of earnings downgrades in the last year, as China’s reopening and slowing inflationary pressures…
(Reuters) – The $26,500-per-year price tag for Eisai Co Ltd and Biogen Inc’s newly approved Alzheimer’s disease drug is slightly above expectations, but should not dent demand for the promising therapy, Wall…
By Hari Kishan BENGALURU (Reuters) – The dollar’s vice grip on FX markets will loosen a bit this year, according to analysts in a Reuters poll who expect most currencies to post…
LOS ANGELES (Reuters) – FedEx’s plan to slash almost $4 billion in expenses has begun sheltering profits, but analysts say the uncertain economy points to the need for more surgical cuts at…
By Hari Kishan and Indradip Ghosh BENGALURU (Reuters) – House prices in most major property markets will fall in 2023, according to nearly 100 housing market analysts polled by Reuters, but they…
By Hernan Nessi BUENOS AIRES (Reuters) – Argentina inflation is expected to have cooled slightly in November, a Reuters poll of analysts showed on Tuesday, though remains high with prices set to…
(Reuters) – Most big banks and investment managers expect the cryptocurrency market to pick up in 2023 after a brutal year that saw bitcoin sink around 75% from its all-time high in…
By Fergal Smith TORONTO (Reuters) – Canada’s dollar will rally over the coming year as major commodity consumer China loosens its COVID-19 restrictions and the Federal Reserve potentially concludes its campaign to…
WASHINGTON (Reuters) – The U.S. Securities and Exchange Commission said on Monday that AT&T agreed to pay a $6.25 million penalty to settle charges of disclosing nonpublic information to research analysts. AT&T…
By Hari Kishan BENGALURU (Reuters) – A retreat in U.S. house prices will extend into next year, although the expected 12% peak-to-trough drop predicted by analysts polled by Reuters would be just…
By Patturaja Murugaboopathy and Chi Xue (Reuters) – Analysts have upgraded forecasts for Chinese corporate earnings in 2023, on expectations that its economy will benefit from stimulus measures and the easing of…
By Ahmad Ghaddar and Rowena Edwards LONDON (Reuters) – OPEC+ is widely expected to stick to its latest target of reducing oil production by 2 million barrels per day (bpd) when it…
By Indradip Ghosh BENGALURU (Reuters) – Once burning-hot Canadian house prices are expected to tumble a total 17.5% from their peak, roughly double the fall during the 2008-09 financial crisis, in a…
NEW YORK (Reuters) – U.S. savers are being left behind by the Federal Reserve’s aggressive campaign of interest rate rises, and that’s unlikely to change soon. New research from the New York…
By Raghav Mahobe and Nandhini Srinivasan (Reuters) -Provention Bio Inc has priced its diabetes drug teplizumab at $13,850 a vial, it said on Friday, a day after receiving U.S. approval and far…